Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-08-23
2011-08-23
Kam, Chih-Min (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S300000, C530S328000, C424S009100, C424S450000, C424S489000
Reexamination Certificate
active
08003610
ABSTRACT:
A bradykinin B2-receptor antagonist peptide, kinestatin, isolated from toad (Bombina maxima) defensive skin secretion, and analogs thereof, is disclosed. The structure of kinestatin is pGlu-Leu/Ile-Pro-Gly-Leu/Ile-Gly-Pro-Leu/Ile-Arg-NH2. Also disclosed are kinestatin analogs, prodrugs including the peptides, fusion peptides and multimeric peptides including the peptide sequences, pharmaceutical compositions including kinestatin and analogs thereof, prodrugs, fusion and multimeric peptides thereof, nucleic acids encoding kinestatin and analogs thereof, and nucleic acids encoding the fusion and multimeric peptides. Kinestatin and analogs thereof (including the prodrugs and multimeric and/or fusion peptides) can be used to treat and/or prevent disorders associated with bradykinin, including cardiovascular disorders, inflammation, asthma, allergic rhinitis, pain, angiogenesis and the like.
REFERENCES:
patent: WO 86/07263 (1986-12-01), None
N. E. Rhaleb et al., “Structure-Activity Studies of Bradykinin and Related Peptides. B2-Receptor Antagonists”,Hypertension, 17(1): 107-115 (1991).
Tianbao Chen et al., “Kinestatin: A Novel Bradykinin B2 Receptor Antagonist Peptide From the Skin Secretion of the Chinese Toad, Bombina Maxima”,Regulatory Peptides, 116(1-3): 147-154 (2003).
R. Lai et al., “A Novel Bradykinin-Related Peptide From Skin Secretions of Toad Bombina Maxima and Its Precursor Containing Six Identical Copies of the Final Product”,Biochemical and Biophysical Research Communications, 286(2): 259-263 (2001).
Chen Tianbao
Hirst David
O'Rourke Martin
Rao Pingfan
Shaw Chris
Drinker Biddle & Reath LLP
Kam Chih-Min
Queen's University of Belfast
LandOfFree
Bradykinin B 2 receptor antagonist peptide from amphibian skin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bradykinin B 2 receptor antagonist peptide from amphibian skin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bradykinin B 2 receptor antagonist peptide from amphibian skin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2789397